59467-700-27 : NDC 2025 Code

59467-700-27 : Olopatadine Hydrochloride And Mometasone Furoate ( Ryaltris )

Additionally :

You can get information about “59467-700-27” NDC code in 59467-700-27 in HTML format

HTML | 59467-700-27 in TXT (Plain Text) format

TXT | 59467-700-27 in PDF (Portable Document Format)

PDF | 59467-700-27 in XML format

XML formats.

NDC Code : 59467-700-27 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "59467-700-27",
    "PackageDescription": "12 CARTON in 1 BOX (59467-700-27)  / 1 BOTTLE, SPRAY in 1 CARTON / 240 SPRAY, METERED in 1 BOTTLE, SPRAY",
    "NDC11Code": "59467-0700-27",
    "ProductNDC": "59467-700",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ryaltris",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Olopatadine Hydrochloride And Mometasone Furoate",
    "DosageFormName": "SPRAY, METERED",
    "RouteName": "NASAL",
    "StartMarketingDate": "20220815",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA211746",
    "LabelerName": "HIKMA SPECIALTY USA INC.",
    "SubstanceName": "MOMETASONE FUROATE MONOHYDRATE; OLOPATADINE HYDROCHLORIDE",
    "StrengthNumber": "25; 665",
    "StrengthUnit": "ug/1; ug/1",
    "Pharm_Classes": "Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-05-20",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20251231",
    "StartMarketingDatePackage": "20220815",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}